Mapping why specific groups of diabetes follow a specific track of complications (poor glycemic control, more severe hypoglycemia, more insulin requirement, and younger or late age of presentation) is vital to provide the specific needs for a special subgroup of diabetes based on the genomic and clinical characters [17]. This evidence concerns the gene INS and diabetes mellitus.